Mandatory reporting of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia and Clostridium difficile infection (CDI) has been in place for National Health Service (NHS) acute Trusts for several years. Independent Sector (IS) hospitals began reporting MRSA bacteraemia and CDI, from January 2008. In January 2011 this scheme was extended to include surveillance of MSSA bacteraemia and E. coli bacteraemia in June 2011. IS healthcare organisations providing regulated activities undertake surveillance on HCAIs and report to Public Health England (PHE) as specified in the Code of Practice. Please refer to the UK Legislation website and The Health and Social Care Act 2008 for more information.
Whilst reporting guidelines and case definitions for IS organisations and NHS acute Trusts are identical there have been numerous issues specific to IS surveillance which are further discussed in the commentaries below.
Such issues also mean that to date it is not possible to draw comparisons between IS and NHS data on these published data.
The latest publication includes 6 months counts of MRSA, MSSA and E. coli bacteraemia and CDI within those IS organisations who reported between April 2012 and September 2012.
Archive data for April 2011- March 2012 is available below.
IS Reporting Summary - April 2013
Descriptive commentary - July 2009
Archive Reporting Summaries - October 2012
Archive Commentary:
Commentary accompanying the Independent Sector MRSA, MSSA, E.coli bacteraemia and CDI publication- October 2012 (PDF, 383 KB)
These tables are provided for historical reference and will not be updated. Please note that the numbers may have changed but the overall trend will remain the same.
Previous publications are available on request.
Last reviewed: 28 March 2013